Medicus IT, a leading IT Managed Services and Cybersecurity provider to healthcare providers, today announced the appointment of Shelby Kobes as Senior Director of Nonprofit & Community Health. The ...
Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow ...
Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow ...
Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow patients to avoid ...
Medicus Pharma (NASDAQ:MDCX) said on Monday that new analysis of data from a mid-stage clinical trial of its SkinJect ...
Dr. Raza Bokhari, Executive Chairman & CEO will participate in panel discussions and highlight Company's AI-enabled Drug ...
The Company Reported 73% Clinical Clearance in the 200-µg cohort at Day 57PHILADELPHIA, March 09, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a ...
Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to provide additional details from the company’s Phase ...
Pro Medicus and Telix Pharmaceuticals are likely to be ejected from key S&P/ASX indices at the next reweighting, but 4D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results